DeutschNewstral
Article
Hhamodia.com on 2017-02-02 18:27
Merck Scores a Hit With Keytruda, Watches Spending in 4Q
Related news
Merck scores a hit with Keytruda, watches spending in 4Qthenewstribune.com
Merck beats expectations, helped by Keytruda salesdailyherald.com
Merck tops 4Q profit forecastsdothaneagle.com
COVID-19 treatment, Keytruda boost Merck in 1QSeattle Times- BMerck Stock Climbs on Earnings Beat as Keytruda Sales Jumpbarrons.com
Merck 4Q powered by cancer treatment salesbradenton.com- BMerck Delivers on Earnings as Sales of Cancer Drug Keytruda Soarbarrons.com
- DMerck Posts Narrower-Than Expected Loss, Lifts Sales Outlook on Keytruda Boostdcourier.com
How Important Is Keytruda For Merck?Forbes- Drugmaker Merck posts spike in 4Q profit, beats forecastsdothaneagle.com
- Drugmaker Merck tops 3Q forecasts as Keytruda sales jump 20%Seattle Times
Merck beats 4Q profit forecastsseattletimes.com- Merck Maintaining Its Lofty Valuation Due To Keytruda MomentumForbes
- MMerck announces positive results for Keytruda in melanoma trialmarketwatch.com
Merck sales soar but 3Q profit dips on higher spendingThe Wichita Eagle- MMerck stock rises 2.4% after new Keytruda lung cancer approvalmarketwatch.com
- MMerck shares slip as Keytruda fails another clinical trialmarketwatch.com
- Exxon clamps down on spending, 4Q revenue nearly flatseattletimes.com